FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174224552> ?p ?o ?g. }

• W3174224552 endingPage "250" @default.
• W3174224552 startingPage "241" @default.
• W3174224552 abstract "Purpose: to determine whether pre-surgical treatment using long-acting somatostatin analogues (SSAs) may improve surgical outcomes in acromegaly. Methods: retrospective study of 48 patients with acromegaly operated by endoscopic transsphenoidal approach and for first time. Surgical remission was evaluated based on the 2010 criteria. Results: most patients, 83.3% (n = 40), harbored macroadenomas and 31.3% (n = 15) invasive pituitary adenomas. In this case, 14 patients were treated with lanreotide LAR and 6 with octreotide LAR, median monthly doses of 97.5 [range 60–120] and 20 [range 20–30] mg, respectively, for at least 3 months preoperatively. Presurgical variables were comparable between pre-treated and untreated patients (p > 0.05). Surgical remission was more frequent in those pre-treated with monthly doses ≥90 mg of lanreotide or ≥30 mg of octreotide than in untreated or pre-treated with lower doses (OR = 4.64, p = 0.025). However, no differences were found between pre-treated and untreated patients when lower doses were included or between those treated for longer than 6 months compared to those untreated or pre-treated for shorter than 6 months. Similarly, no differences were found either in terms of surgical or endocrine complications (OR = 0.65, p = 0.570), independently of the doses and the duration of SSA treatment (p > 0.05). Conclusions: the dose of SSAs is a key factor during pre-surgical treatment, since the beneficial effects in surgical remission were observed with monthly doses equal or higher than 90 mg of lanreotide and 30 mg of octreotide, but not with lower doses." @default.
• W3174224552 created "2021-07-05" @default.
• W3174224552 creator A5014833116 @default.
• W3174224552 creator A5037734198 @default.
• W3174224552 creator A5043490939 @default.
• W3174224552 creator A5048873029 @default.
• W3174224552 creator A5075213191 @default.
• W3174224552 creator A5085895275 @default.
• W3174224552 creator A5088359843 @default.
• W3174224552 date "2021-08-05" @default.
• W3174224552 modified "2023-10-18" @default.
• W3174224552 title "The Dose of Somatostatin Analogues during Pre-Surgical Treatment Is a Key Factor to Achieve Surgical Remission in Acromegaly" @default.
• W3174224552 cites W1862508240 @default.
• W3174224552 cites W1870125158 @default.
• W3174224552 cites W1876291110 @default.
• W3174224552 cites W1970109874 @default.
• W3174224552 cites W1972904691 @default.
• W3174224552 cites W1991642990 @default.
• W3174224552 cites W2000355136 @default.
• W3174224552 cites W2025997743 @default.
• W3174224552 cites W2032467001 @default.
• W3174224552 cites W2040054585 @default.
• W3174224552 cites W2049558521 @default.
• W3174224552 cites W2057277019 @default.
• W3174224552 cites W2076895614 @default.
• W3174224552 cites W2081324142 @default.
• W3174224552 cites W2088691443 @default.
• W3174224552 cites W2095591038 @default.
• W3174224552 cites W2101992531 @default.
• W3174224552 cites W2108052917 @default.
• W3174224552 cites W2116114460 @default.
• W3174224552 cites W2121103313 @default.
• W3174224552 cites W2134282876 @default.
• W3174224552 cites W2138325975 @default.
• W3174224552 cites W2155465275 @default.
• W3174224552 cites W2160989555 @default.
• W3174224552 cites W2163021856 @default.
• W3174224552 cites W2242576968 @default.
• W3174224552 cites W2268103841 @default.
• W3174224552 cites W2790308024 @default.
• W3174224552 cites W2898605951 @default.
• W3174224552 cites W2977293341 @default.
• W3174224552 cites W2982376878 @default.
• W3174224552 cites W3011221155 @default.
• W3174224552 cites W3028295041 @default.
• W3174224552 cites W3048835656 @default.
• W3174224552 cites W3111496817 @default.
• W3174224552 doi "https://doi.org/10.3390/endocrines2030023" @default.
• W3174224552 hasPublicationYear "2021" @default.
• W3174224552 type Work @default.
• W3174224552 sameAs 3174224552 @default.
• W3174224552 citedByCount "1" @default.
• W3174224552 countsByYear W31742245522023 @default.
• W3174224552 crossrefType "journal-article" @default.
• W3174224552 hasAuthorship W3174224552A5014833116 @default.
• W3174224552 hasAuthorship W3174224552A5037734198 @default.
• W3174224552 hasAuthorship W3174224552A5043490939 @default.
• W3174224552 hasAuthorship W3174224552A5048873029 @default.
• W3174224552 hasAuthorship W3174224552A5075213191 @default.
• W3174224552 hasAuthorship W3174224552A5085895275 @default.
• W3174224552 hasAuthorship W3174224552A5088359843 @default.
• W3174224552 hasBestOaLocation W31742245521 @default.
• W3174224552 hasConcept C126322002 @default.
• W3174224552 hasConcept C141071460 @default.
• W3174224552 hasConcept C167135981 @default.
• W3174224552 hasConcept C2776297358 @default.
• W3174224552 hasConcept C2777428134 @default.
• W3174224552 hasConcept C2777433750 @default.
• W3174224552 hasConcept C2779318953 @default.
• W3174224552 hasConcept C2779609023 @default.
• W3174224552 hasConcept C2779653919 @default.
• W3174224552 hasConcept C2781025020 @default.
• W3174224552 hasConcept C2984496839 @default.
• W3174224552 hasConcept C46699223 @default.
• W3174224552 hasConcept C71315377 @default.
• W3174224552 hasConcept C71924100 @default.
• W3174224552 hasConcept C90924648 @default.
• W3174224552 hasConceptScore W3174224552C126322002 @default.
• W3174224552 hasConceptScore W3174224552C141071460 @default.
• W3174224552 hasConceptScore W3174224552C167135981 @default.
• W3174224552 hasConceptScore W3174224552C2776297358 @default.
• W3174224552 hasConceptScore W3174224552C2777428134 @default.
• W3174224552 hasConceptScore W3174224552C2777433750 @default.
• W3174224552 hasConceptScore W3174224552C2779318953 @default.
• W3174224552 hasConceptScore W3174224552C2779609023 @default.
• W3174224552 hasConceptScore W3174224552C2779653919 @default.
• W3174224552 hasConceptScore W3174224552C2781025020 @default.
• W3174224552 hasConceptScore W3174224552C2984496839 @default.
• W3174224552 hasConceptScore W3174224552C46699223 @default.
• W3174224552 hasConceptScore W3174224552C71315377 @default.
• W3174224552 hasConceptScore W3174224552C71924100 @default.
• W3174224552 hasConceptScore W3174224552C90924648 @default.
• W3174224552 hasIssue "3" @default.
• W3174224552 hasLocation W31742245521 @default.
• W3174224552 hasLocation W31742245522 @default.
• W3174224552 hasLocation W31742245523 @default.
• W3174224552 hasOpenAccess W3174224552 @default.
• W3174224552 hasPrimaryLocation W31742245521 @default.

• next